(Total Views: 343)
Posted On: 01/05/2020 11:49:55 AM
Post# of 149275
I think we all hope all of these catalysts will happen quickly, but we only need to look at our last history (and that of most pharmacudical companies). It's simply not realistic.
IMO the only reasonably likely fast payout is a BO. And like most on here I don't think BP will pay what NP believes it's worth.
Each catalyst that's reached will likely have some upward movement with it. Some more than others. But the two main events IMO are uplisting and revenue. Both of which are atleast 6 months out.
Between now and then I hope we see consistent progress in all areas, which I think will require another licensing deal as we need more cash to resume moving all trials forward.
So, my main focus at the moment is another licensing deal on the back of Nash, or even HIV in another market.
IMO the only reasonably likely fast payout is a BO. And like most on here I don't think BP will pay what NP believes it's worth.
Each catalyst that's reached will likely have some upward movement with it. Some more than others. But the two main events IMO are uplisting and revenue. Both of which are atleast 6 months out.
Between now and then I hope we see consistent progress in all areas, which I think will require another licensing deal as we need more cash to resume moving all trials forward.
So, my main focus at the moment is another licensing deal on the back of Nash, or even HIV in another market.
(0)
(0)Scroll down for more posts ▼
